A blood-based noninvasive miRNA signature for predicting survival outcomes in patients with intrahepatic cholangiocarcinoma.
Yuma WadaMitsuo ShimadaYuji MorineTetsuya IkemotoYu SaitoHideo BabaMasaki MoriAjay GoelPublished in: British journal of cancer (2022)
We established a novel miRNA signature that could robustly predict survival outcomes in resected tissues and liquid biopsies to improve the clinical management of patients with ICC.